Barinthus Biotherapeutics plc
BRNS
$0.839
$0.0161.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 110.66M | 106.10M | 117.77M | 129.97M | 142.09M |
| Total Receivables | 7.14M | 21.02M | 5.67M | 6.39M | 7.94M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.86M | 7.06M | 7.81M | 5.09M | 5.40M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.08M | 464.00K | 626.00K | 1.68M | 1.47M |
| Total Current Assets | 125.74M | 134.65M | 131.88M | 143.13M | 156.91M |
|
|
|||||
| Total Current Assets | 125.74M | 134.65M | 131.88M | 143.13M | 156.91M |
| Net Property, Plant & Equipment | 11.76M | 18.16M | 18.25M | 18.94M | 19.40M |
| Long-term Investments | -- | 12.21M | 12.21M | 12.21M | 12.21M |
| Goodwill | -- | 12.21M | 12.21M | 12.21M | 12.21M |
| Total Other Intangibles | 21.95M | 22.74M | 23.53M | 24.32M | 25.11M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 881.00K | 926.00K | 886.00K | 885.00K | 882.00K |
| Total Assets | 160.33M | 188.69M | 186.75M | 199.48M | 214.51M |
|
|
|||||
| Total Accounts Payable | 2.47M | 3.08M | 2.56M | 1.16M | 1.60M |
| Total Accrued Expenses | 9.53M | 7.97M | 10.28M | 8.33M | 9.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.92M | 1.99M | 1.92M | 1.91M | 1.79M |
| Total Finance Division Other Current Liabilities | 1.74M | 2.04M | 839.00K | 1.43M | -- |
| Total Other Current Liabilities | 1.74M | 2.04M | 839.00K | 1.43M | -- |
| Total Current Liabilities | 15.66M | 15.07M | 15.59M | 12.84M | 12.60M |
|
|
|||||
| Total Current Liabilities | 15.66M | 15.07M | 15.59M | 12.84M | 12.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.09M | 10.68M | 10.65M | 10.90M | 11.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.45M | 3.47M | 3.72M | 3.73M | 3.72M |
| Total Liabilities | 30.19M | 29.23M | 29.96M | 27.47M | 27.51M |
|
|
|||||
| Common Stock & APIC | 393.48M | 391.88M | 390.27M | 388.72M | 386.60M |
| Retained Earnings | -237.66M | -217.12M | -209.01M | -192.08M | -176.59M |
| Treasury Stock & Other | -25.78M | -15.47M | -24.65M | -24.81M | -23.23M |
| Total Common Equity | 130.03M | 159.29M | 156.62M | 171.83M | 186.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 130.03M | 159.29M | 156.62M | 171.83M | 186.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 106.00K | 167.00K | 172.00K | 183.00K | 211.00K |
| Total Equity | 130.14M | 159.46M | 156.79M | 172.02M | 187.00M |
|
|
|||||